Comparing three types of arteriovenous fistulas for dialysis access
Comparison of Tree Types of Distal Arteriovenous Fistulas: Snuffbox Fistula (SBAVF), Radiocephalic Fistula (RCAVF) and RCAVF With Venous Branch Patch.
This study is trying to find out which of three types of arteriovenous fistulas works best for people on dialysis to help them get the best access for their treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Wroclaw Medical University Academic / other |
| Locations | 1 site (Wroclaw) |
| Trial ID | NCT06550479 on ClinicalTrials.gov |
What this trial studies
This study evaluates the clinical outcomes of three different types of distal arteriovenous fistulas: the snuffbox arteriovenous fistula (SBAVF), the radiocephalic arteriovenous fistula (RCAVF), and the RCAVF with a venous branch patch. The goal is to determine which type provides the best vascular access for patients undergoing hemodialysis, particularly focusing on the rates of early failure and maturation of the fistulas. By analyzing patient outcomes, the study aims to provide evidence-based recommendations for optimal vascular access in patients with end-stage renal disease.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old with chronic kidney disease and an estimated glomerular filtration rate of less than 20 mL/min/1.73 m².
Not a fit: Patients with severe heart failure or recent cardiovascular events, as well as those who have previously undergone an anastomosis on the same arm, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved vascular access options for dialysis patients, reducing complications and enhancing treatment efficacy.
How similar studies have performed: While there have been studies on arteriovenous fistulas, this specific comparison of these three types is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged \>18 years * Chronic kidney disease with estimated glomerular filtration rate (eGFR) \<20 mL/min/1.73 m2 Exclusion Criteria: * Heart failure of New York Heart Association functional class III or IV, * Episode of cardio- or cerebrovascular event or receiving intervention therapy within 3 months prior to screening. * The patient had the primary anastomosis in the past on ipsilateral extremity
Where this trial is running
Wroclaw
- Department of Nephrology and Transplantation Medicine — Wroclaw, Poland (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.